Among them, SHMT2 is considered to be an important factor in the metabolism of serine and glycine of several cancer cell types (including BC) (27), which is crucial in the development of cancer cells, and high SHMT2 expression is linked to poor prognosis in BC (28). This evidence concerns the gene SHMT2 and breast cancer.